The Southern Medical Journal (SMJ) is the official, peer-reviewed journal of the Southern Medical Association. It has a multidisciplinary and inter-professional focus that covers a broad range of topics relevant to physicians and other healthcare specialists.

SMJ // Article

Editorial

The Many Guises of Pheochromocytoma: Insights from a Case Report

Authors: Alejandro L. Rosas, MD

Abstract

Pheochromocytoma is a rare neuroendocrine tumor with heterogeneous and often deadly clinical manifestations.


In this issue of the Southern Medical Journal, Anaforoglu et al1 report the first case in the literature of myoglobinuric acute renal failure in a patient with bilateral, probably familial, pheochromocytoma. The case not only adds to the more than 80 described clinical manifestations of pheochromocytoma but also illustrates the clinical import that advances in biochemical diagnosis, genetics, anesthesia, and surgical technique have in the current management of pheochromocytoma.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Anaforoglu I, Ertorer ME, Haydardedeoglu FE, et al. Rhabdomyolysis and acute myoglobinuric renal failure in a patient with bilateral pheochromocytoma following open pyelotomy. South Med J 2008;101:425–427.
2. Manger WM, Gifford RW. Clinical and Experimental Pheochromocytoma. Cambridge, MA, Blackwell Science, 1996, pp 189–204.
3. Grossman A, Pacak K, Sawka A. Biochemical diagnosis and localization of pheochromocytoma: can we reach a consensus? Ann N Y Acad Sci 2006;1073:332–347.
4. Sawka AM, Jaeschke R, Singh RJ, et al. A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab 2003;88:553–558.
5. Shulkin BL, Ilias I, Sisson JC, et al. Current trends in functional imaging of pheochromocytomas and paragangliomas. Ann N Y Acad Sci 2006;1073:374–382.
6. Prys-Roberts C. Phaeochromocytoma-recent progress in its management. Br J Anaesth 2000;85:44–57.
7. Bravo EL, Tagle R. Pheochromocytoma: state of the art and future prospects. Endocr Rev 2003;24:539–553.
8. James MF. Use of magnesium sulphate in the anesthetic management of phaeochromocytoma: a review of 17 anaesthetics. Br J Anesth 1989;62:616–623.
9. Proye C, Thevenin D, Cecat P, et al. Exclusive use of calcium channel blockers in perioperative and intraoperative control of pheochromocytomas: hemodynamics and free catecholamine assays in ten consecutive patients. Surgery 1989;106:1149–1154.
10. Gimenez-Roquelpo AP. New advances in the genetics of pheochromocytoma and paraganglioma syndromes. Ann N Y Acad Sci 2006;1073:112–121.
11. Duh, Quan-Yang. Evolving surgical management for patients with pheochromocytoma. J Clin Endocrinol Metab 2001;86:1477–1479.
n